These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2476926)

  • 21. Propafenone interacts stereoselectively with beta 1- and beta 2-adrenergic receptors.
    Burnett DM; Gal J; Zahniser NR; Nies AS
    J Cardiovasc Pharmacol; 1988; 12(5):615-9. PubMed ID: 2468063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R
    Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-adrenoceptor recognition sites in living lymphocytes: a model for receptor properties in human disease?
    Remien J
    Eur J Respir Dis Suppl; 1984; 135():208-14. PubMed ID: 6329805
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multicenter comparative studies of the effectiveness and tolerance of propafenone and disopyramide in the treatment of premature ventricular beats].
    Lukasik S; Nowosad H; Grzelak H; Kowalewski W; Kowalisko A
    Pol Arch Med Wewn; 1987 Jun; 77(6):291-9. PubMed ID: 2482478
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues.
    Buxton BF; Jones CR; Molenaar P; Summers RJ
    Br J Pharmacol; 1987 Oct; 92(2):299-310. PubMed ID: 2823947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 2-adrenoceptor up-regulation in relation to cAMP production in human lymphocytes after physical exercise.
    Graafsma SJ; van Tits LJ; Willems PH; Hectors MP; Rodrigues de Miranda JF; De Pont JJ; Thien T
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):142S-144S. PubMed ID: 2176520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beta-adrenoceptor of pig coronary arteries: determination of beta 1 and beta 2 subtypes by radioligand binding.
    Schwartz J; Velly J
    Br J Pharmacol; 1983 Jun; 79(2):409-14. PubMed ID: 6317109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)].
    Dobrotvorskaia TE; Koroleva ON; Gordina OV; Marakanova AV
    Klin Med (Mosk); 1996; 74(3):51-3. PubMed ID: 8926706
    [No Abstract]   [Full Text] [Related]  

  • 30. [Radioligand Method of Assessment of β-Adrenoceptor's Activity on Human T-Lymphocytes].
    Agapova OY; Skoblov YS; Zykov KA; Rvacheva AV; Beilina VB; Masenko VP; Chazova IE
    Bioorg Khim; 2015; 41(5):592-8. PubMed ID: 26762097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of triiodothyronine on the beta adrenergic receptor system in human lymphocytes].
    Nedvídková J; Vavrejnová V
    Cas Lek Cesk; 1986 Aug; 125(33):1035-8. PubMed ID: 3019549
    [No Abstract]   [Full Text] [Related]  

  • 34. Pertussis toxin pretreatment alters agonist binding to beta-adrenoceptors in rabbit ventricular myocardium.
    Akaishi Y; Hattori Y; Kanno M; Sakuma I; Kitabatake A
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):171-9. PubMed ID: 7994562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
    Libersa C; Caron J; Pladys A; Beuscart R; Kacet S; Wajman A; Connell C; Dupuis B; Lekieffre J
    Clin Cardiol; 1987 Jul; 10(7):405-10. PubMed ID: 2440632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
    Sillence MN; Matthews ML
    Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autonomic effects of antiarrhythmic drugs and their importance.
    Lombardi F; Torzillo D; Sandrone G; Dalla Vecchia L; Cappiello E
    Eur Heart J; 1992 Nov; 13 Suppl F():38-43. PubMed ID: 1282464
    [No Abstract]   [Full Text] [Related]  

  • 38. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antiarrhythmic effect and blood levels of propafenone].
    Li ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Feb; 15(1):31-3. PubMed ID: 2440653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.